| Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia (NCT07563179) | Shenzhen University General Hospital | 2026-04-21 |
| Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma (NCT07508605) | Shenzhen University General Hospital | 2025-01-01 |
| Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies (NCT07584889) | Shenzhen University General Hospital | 2024-04-20 |
| Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients (NCT06234072) | Shenzhen University General Hospital | 2024-02-01 |
| Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors (NCT07399769) | Shenzhen University General Hospital | 2024-01-01 |
| Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma (NCT07097207) | Shenzhen University General Hospital | 2023-10-01 |
| BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma (NCT06644443) | Shenzhen University General Hospital | 2023-07-15 |
| Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma (NCT05620693) | Shenzhen University General Hospital | 2022-11-11 |
| Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma (NCT05620706) | Shenzhen University General Hospital | 2022-11-01 |
| CD7 CAR-T Cells in T-cell Lymphoma/Leukemia (NCT05620680) | Shenzhen University General Hospital | 2022-10-01 |
| Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T (NCT05620732) | Shenzhen University General Hospital | 2022-10-01 |
| Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease (NCT05152160) | Shenzhen University General Hospital | 2021-08-01 |
| B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma (NCT05150522) | Shenzhen University General Hospital | 2021-07-01 |
| CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer (NCT05143151) | Shenzhen University General Hospital | 2021-07-01 |
| Treatment of Malignant Tumors With NK Cell (NCT05143125) | Shenzhen University General Hospital | 2021-02-05 |
| Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (NCT05164042) | Shenzhen University General Hospital | 2021-02-05 |
| Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Lymphoma (NCT05143112) | Shenzhen University General Hospital | 2021-02-05 |
| Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine (NCT04672473) | Shenzhen University General Hospital | 2020-10-30 |
| Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia (NCT04723901) | Shenzhen University General Hospital | 2020-10-20 |
| The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia (NCT06904859) | Shenzhen University General Hospital | 2019-01-01 |